Care for end-stage kidney disease in China: progress, challenges, and recommendations
Summary: This review comprehensively evaluates China’s progress in care of end-stage kidney disease (ESKD) by identifying achievements and gaps, reviewing ESKD-related policy initiatives, and proposing policy recommendations. In the past decade, China has made laudable progress in access to ESKD car...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | The Lancet Regional Health. Western Pacific |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666606524002621 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850254186357194752 |
|---|---|
| author | Tiange Chen Xuefeng Sun Sian Tsuei Ruirui Yang Winnie Yip Hongqiao Fu |
| author_facet | Tiange Chen Xuefeng Sun Sian Tsuei Ruirui Yang Winnie Yip Hongqiao Fu |
| author_sort | Tiange Chen |
| collection | DOAJ |
| description | Summary: This review comprehensively evaluates China’s progress in care of end-stage kidney disease (ESKD) by identifying achievements and gaps, reviewing ESKD-related policy initiatives, and proposing policy recommendations. In the past decade, China has made laudable progress in access to ESKD care with narrowed difference between the number of patients needing and receiving kidney replacement therapies (KRT). China has also experienced significant improvements in clinical quality and outcomes of ESKD care. These achievements stem from concerted efforts in advocating effective policies, increasing fiscal subsidies, re-designing health insurance schemes, encouraging healthcare delivery from both public and private sectors, and improving quality regulation. However, challenges remain, including inequitable access to care across regions and groups, and suboptimal quality and outcomes in some underdeveloped areas. To address these gaps, we recommend reforming the financing policy, adopting quality-based payment methods, strengthening quality monitoring system, improving chronic kidney disease prevention and management, and developing alternative KRT modalities. |
| format | Article |
| id | doaj-art-ff71daf07e0846efa252b46427860745 |
| institution | OA Journals |
| issn | 2666-6065 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | The Lancet Regional Health. Western Pacific |
| spelling | doaj-art-ff71daf07e0846efa252b464278607452025-08-20T01:57:11ZengElsevierThe Lancet Regional Health. Western Pacific2666-60652025-01-015410126810.1016/j.lanwpc.2024.101268Care for end-stage kidney disease in China: progress, challenges, and recommendationsTiange Chen0Xuefeng Sun1Sian Tsuei2Ruirui Yang3Winnie Yip4Hongqiao Fu5School of Public Health, Peking University Health Center, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese People’s Liberation Army General Hospital, Beijing, China; State Key Laboratory of Kidney Diseases, First Medical Center of Chinese People’s Liberation Army General Hospital, Beijing, China; National Clinical Research Center for Kidney Diseases, First Medical Center of Chinese People’s Liberation Army General Hospital, Beijing, ChinaDepartment of Family Practice, University of British Columbia, Vancouver, British Columbia, Canada; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, CanadaSchool of Public Health, Peking University Health Center, Beijing, ChinaDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USASchool of Public Health, Peking University Health Center, Beijing, China; Corresponding author. Department of Health Policy and Management, School of Public Health, Peking University Health Science Center, Beijing 100191, China.Summary: This review comprehensively evaluates China’s progress in care of end-stage kidney disease (ESKD) by identifying achievements and gaps, reviewing ESKD-related policy initiatives, and proposing policy recommendations. In the past decade, China has made laudable progress in access to ESKD care with narrowed difference between the number of patients needing and receiving kidney replacement therapies (KRT). China has also experienced significant improvements in clinical quality and outcomes of ESKD care. These achievements stem from concerted efforts in advocating effective policies, increasing fiscal subsidies, re-designing health insurance schemes, encouraging healthcare delivery from both public and private sectors, and improving quality regulation. However, challenges remain, including inequitable access to care across regions and groups, and suboptimal quality and outcomes in some underdeveloped areas. To address these gaps, we recommend reforming the financing policy, adopting quality-based payment methods, strengthening quality monitoring system, improving chronic kidney disease prevention and management, and developing alternative KRT modalities.http://www.sciencedirect.com/science/article/pii/S2666606524002621End-stage kidney diseaseKidney replacement therapyAccessQuality and outcomeHealth policyChina |
| spellingShingle | Tiange Chen Xuefeng Sun Sian Tsuei Ruirui Yang Winnie Yip Hongqiao Fu Care for end-stage kidney disease in China: progress, challenges, and recommendations The Lancet Regional Health. Western Pacific End-stage kidney disease Kidney replacement therapy Access Quality and outcome Health policy China |
| title | Care for end-stage kidney disease in China: progress, challenges, and recommendations |
| title_full | Care for end-stage kidney disease in China: progress, challenges, and recommendations |
| title_fullStr | Care for end-stage kidney disease in China: progress, challenges, and recommendations |
| title_full_unstemmed | Care for end-stage kidney disease in China: progress, challenges, and recommendations |
| title_short | Care for end-stage kidney disease in China: progress, challenges, and recommendations |
| title_sort | care for end stage kidney disease in china progress challenges and recommendations |
| topic | End-stage kidney disease Kidney replacement therapy Access Quality and outcome Health policy China |
| url | http://www.sciencedirect.com/science/article/pii/S2666606524002621 |
| work_keys_str_mv | AT tiangechen careforendstagekidneydiseaseinchinaprogresschallengesandrecommendations AT xuefengsun careforendstagekidneydiseaseinchinaprogresschallengesandrecommendations AT siantsuei careforendstagekidneydiseaseinchinaprogresschallengesandrecommendations AT ruiruiyang careforendstagekidneydiseaseinchinaprogresschallengesandrecommendations AT winnieyip careforendstagekidneydiseaseinchinaprogresschallengesandrecommendations AT hongqiaofu careforendstagekidneydiseaseinchinaprogresschallengesandrecommendations |